{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:34:16Z","timestamp":1781177656941,"version":"3.54.1"},"reference-count":40,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avicenna J Med"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) is the culprit behind the pandemic across the globe in recent decades. Variants of SARS-CoV especially coronavirus disease 2019 (COVID-19)-related fungus might not be identified or might be misdiagnosed on a worldwide scale. Patients of COVID-19 acquired invasive mycoses, especially if they are very ill or immunosuppressed. Clinical intervention based on various standard guidelines would be necessary to guarantee that Aspergillus and Candida-infected COVID-19 patients are adequately treated. To facilitate clinical professionals, doctors, paramedics, and laboratory staff in the treatment of various variants of COVID-19 patients with concurrent aspergillosis, candidiasis, mucormycosis, or cryptococcosis, a tabulation format is drafted in this study. We believe it is prudent to take into account the general nature, and variety of the mycosis that is arriving, the strength and limits of the diagnostic tools, clinical conditions, and the need for standardized or customized therapy in various coronavirus-infected patients.<\/jats:p>","DOI":"10.1055\/s-0043-1770921","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T23:09:01Z","timestamp":1688425741000},"page":"131-137","source":"Crossref","is-referenced-by-count":4,"title":["Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management"],"prefix":"10.1055","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-8318","authenticated-orcid":false,"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Quality Control & Assurance, Hakeem Abdul Hameed Centenary Hospital & Hamdard Institute of Medical Sciences & Research, Jamia Hamdard, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-5410","authenticated-orcid":false,"given":"Gulnaz","family":"Bano","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Pharmacy Practice, School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-3799","authenticated-orcid":false,"given":"Abdul","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Teerthanker Mahaveer College of Pharmacy, Moradabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1522-2689","authenticated-orcid":false,"given":"Yuman","family":"Rasool","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8584-4386","authenticated-orcid":false,"given":"Samrina","family":"Manzar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-5162","authenticated-orcid":false,"given":"Tarun","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Maharishi Markandeshwar College of Pharmacy, MM(DU), Mullana, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Maity","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Maharishi Markandeshwar College of Pharmacy, MM(DU), Mullana, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"W J Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"G Song","year":"2020","journal-title":"Mycopathologia"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"S M Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"D Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"A Skiada","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report","volume":"53","author":"E SD Monte Junior","year":"2020","journal-title":"Clin Endosc"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/aian.AIAN_421_21","article-title":"Epidemic of mucormycosis in COVID-19 pandemic: a position paper","volume":"25","author":"R Kulkarni","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3174\/ajnr.A1808","article-title":"The \u201cBlack Turbinate\u201d sign: an early MR imaging finding of nasal mucormycosis","volume":"31","author":"S Safder","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jof5010024","article-title":"Molecular strategies to diagnose mucormycosis","volume":"5","author":"L Millon","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"S 01","key":"ref10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/49.suppl_1.81","article-title":"Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients","volume":"49","author":"P J Cagnoni","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"05","key":"ref11","first-page":"1156","article-title":"Practical guidelines for preparing and administering amphotericin B","volume":"49","author":"P E Kintzel","year":"1992","journal-title":"Am J Hosp Pharm"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"O A Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"F M Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"R Unnikrishnan","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"D P Kontoyiannis","year":"2011","journal-title":"Blood"},{"issue":"04","key":"ref16","first-page":"18026","article-title":"Invasive candidiasis; a review article","volume":"11","author":"P G Pappas","year":"2018","journal-title":"Jundishapur J Microbiol"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/jof6040211","article-title":"COVID-19-Associated candidiasis (CAC):an underestimated complication in the absence of immunological predisposition?","volume":"6","author":"A Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20506\/rst.23.2.1494","article-title":"Factors and determinants of disease emergence","volume":"23","author":"S S Morse","year":"2004","journal-title":"Rev Sci Tech"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","volume":"34","author":"S Antinori","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"09","key":"ref20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"C J Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref21","first-page":"65","article-title":"Laboratory diagnosis of invasive candidiasis","volume":"43","author":"A N Ellepola","year":"2005","journal-title":"J Microbiol"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","article-title":"Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009","volume":"55","author":"M A Pfaller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/myc.12963","article-title":"European Confederation of Medical Mycology (ECMM). ECMM CandiReg-A ready-to-use platform for outbreaks and epidemiological studies","volume":"62","author":"P Koehler","year":"2019","journal-title":"Mycoses"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jof4030097","article-title":"Treatment of invasive candidiasis: a narrative review","volume":"4","author":"R Ben-Ami","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/clinids\/21.2.323","article-title":"Meningitis caused by Candida species: an emerging problem in neurosurgical patients","volume":"21","author":"M H Nguyen","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"C J Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/fmb.15.138","article-title":"Current laboratory approaches to diagnosis of CNS fungal infections","volume":"11","author":"J L Lyons","year":"2016","journal-title":"Future Microbiol"},{"issue":"07","key":"ref28","first-page":"e1634","article-title":"A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","volume":"73","author":"P L White","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11046-017-0115-y","article-title":"Risk factors and outcomes of invasive fungal infections in allogeneic hematopoietic cell transplant recipients","volume":"182","author":"M H Miceli","year":"2017","journal-title":"Mycopathologia"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/ajt.15890","article-title":"Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve","volume":"20","author":"J A Fishman","year":"2020","journal-title":"Am J Transplant"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.jcf.2020.03.017","article-title":"Asymptomatic case of Covid-19 in an infant with cystic fibrosis","volume":"19","author":"P Poli","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"P Koehler","year":"2020","journal-title":"Mycoses"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chom.2010.01.010","article-title":"Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection","volume":"7","author":"A M Jamieson","year":"2010","journal-title":"Cell Host Microbe"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"S I Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"T F Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline","volume":"200","author":"C A Hage","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref38","first-page":"e8254","article-title":"Disseminated cryptococcosis in a patient with metastatic prostate cancer who died in the coronavirus disease 2019 (COVID-19) outbreak","volume":"12","author":"M Passerini","year":"2020","journal-title":"Cureus"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ccr3.3668","article-title":"Cryptococcemia in a patient with COVID-19: a case report","volume":"9","author":"M Y Khatib","year":"2020","journal-title":"Clin Case Rep"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/mmy\/myy086","article-title":"Pulmonary cryptococcosis: a review of pathobiology and clinical aspects","volume":"57","author":"F Setianingrum","year":"2019","journal-title":"Med Mycol"},{"issue":"S 01","key":"ref41","first-page":"16","article-title":"Update on the diagnosis of invasive fungal infection","volume":"30","author":"E Ib\u00e1\u00f1ez-Mart\u00ednez","year":"2017","journal-title":"Rev Esp Quimioter"}],"container-title":["Avicenna Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1770921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T23:13:11Z","timestamp":1696461191000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1770921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,10,4]]},"published-print":{"date-parts":[[2023,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1770921","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2231-0770","2249-4464"],"issn-type":[{"value":"2231-0770","type":"print"},{"value":"2249-4464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}